FOCL · Edap Tms SA
$4.23
+0.03 (+0.71%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing no longer states the doubt (first flagged May 7, 2026).
View the 10-Q filed Aug 14, 2026Market Cap
$222.39M
Shares
47.22M
Volume · Oct 5
93.02K
Avg daily vol (3M)
114.17K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.23
Open$4.25
Day$4.20–4.40
52W close$1.81–6.34
Avg vol 30d81K
Short int246K · 0.5% float · 3.1d
Short vol38%
Last earningsAug 13, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 14
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 4 wks
filed Aug 14, 2026
call held Mar 25, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+80.3%
Trailing year
Short interest
0.5%
Latest settlement · 3.1 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−2%
below
Price vs 50-day avg
−11%
below
RSI (14)
43
neutral
MACD trend
Positive
52-week position
53%
mid-range
Momentum
relative strength
1-month return
+2%
trailing
6-month return
+26%
trailing
YTD return
+29%
this year
Relative strength
+14%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Distributing
-3% holders QoQ · +4 funds added
Insider flow
Accumulating
Net +$551.0K over 90 days · 0% sells
Short interest
Falling
0.52% of float · ▼ -13.7% MoM · 3.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
38 holders — mid 3-yr range
Squeeze score
31
low risk · 0–100
Fundamentals
Revenue growth
+2%
Y/Y
Gross margin
43%
expanding
EPS growth
−42%
Y/Y
Balance sheet
$2.5M
net cash
Quant / Vol
risk profile
Volatility
78%
annualized · 1-yr
Max drawdown
−36%
past year
ATR
6.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the 8-K filed Aug 11, 2026
Gross Margin
· second quarter of 2026
54% – 56%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−2%
Neutral
Price vs 50-day avg
−11%
Bearish
RSI (14)
43
Neutral
MACD trend
Positive
Bullish
52-week position
53%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Distributing
-3% holders QoQ · +4 funds added
Insider flow
Accumulating
Net +$551.0K over 90 days · 0% sells
Short interest
Falling
0.52% of float · ▼ -13.7% MoM · 3.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
38 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $2
Now $4 · 53%
Range high $6
vs 200-day avg -2%
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Focal One System Installed Base | 184 | second quarter of 2026 | — |
| International Focal One System Installed Base | 88 | second quarter of 2026 | — |
| U.S. Focal One System Installed Base | 96 | second quarter of 2026 | — |
| U.S. Procedure Volume Growth | 47% | second quarter of 2026 | — |
| Focal One Systems | 96 | as of June 30, 2026 | — |
| Focal One Treatment Clinical Sites | 254 | as of Dec. 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FOCL
this stock
Edap Tms SA
|
$222.39M | +28.6% | +1.6% | — | 0.5% |
|
MCK
Mckesson Corp
|
$101.04B | +11.6% | +3.1% | 23.3 | 2.5% |
|
COR
Cencora, Inc.
|
$57.74B | -6.8% | +9.3% | 22.5 | 2.3% |
|
CAH
Cardinal Health Inc
|
$52.08B | +13.4% | +14.2% | — | 2.9% |
|
HSIC
Henry Schein Inc
|
$9.63B | +11.4% | +5.9% | 25.2 | 6.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FOCL | -6.6% | +1.9% | +25.5% | -5.4% | +28.6% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | -7.8% | +1.3% | +14.0% | -7.0% | +15.0% |